Common risk alleles for schizophrenia within the major histocompatibility complex predict white matter microstructure.


Journal

Translational psychiatry
ISSN: 2158-3188
Titre abrégé: Transl Psychiatry
Pays: United States
ID NLM: 101562664

Informations de publication

Date de publication:
22 Apr 2024
Historique:
received: 23 02 2024
accepted: 12 04 2024
revised: 15 03 2024
medline: 23 4 2024
pubmed: 23 4 2024
entrez: 22 4 2024
Statut: epublish

Résumé

Recent research has highlighted the role of complement genes in shaping the microstructure of the brain during early development, and in contributing to common allele risk for Schizophrenia. We hypothesised that common risk variants for schizophrenia within complement genes will associate with structural changes in white matter microstructure within tracts innervating the frontal lobe. Results showed that risk alleles within the complement gene set, but also intergenic alleles, significantly predict axonal density in white matter tracts connecting frontal cortex with parietal, temporal and occipital cortices. Specifically, risk alleles within the Major Histocompatibility Complex region in chromosome 6 appeared to drive these associations. No significant associations were found for the orientation dispersion index. These results suggest that changes in axonal packing - but not in axonal coherence - determined by common risk alleles within the MHC genomic region - including variants related to the Complement system - appear as a potential neurobiological mechanism for schizophrenia.

Identifiants

pubmed: 38649377
doi: 10.1038/s41398-024-02910-2
pii: 10.1038/s41398-024-02910-2
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

194

Subventions

Organisme : RCUK | Medical Research Council (MRC)
ID : MR/L010305/1
Organisme : RCUK | Medical Research Council (MRC)
ID : MR/P005748/1
Organisme : RCUK | Medical Research Council (MRC)
ID : MR/T04604X/1
Organisme : RCUK | Medical Research Council (MRC)
ID : MR/L023784/2

Informations de copyright

© 2024. The Author(s).

Références

Sullivan PF, Kendler KS, Neale MC. Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies. Arch Gen Psychiatry. 2003;60:1187–92.
doi: 10.1001/archpsyc.60.12.1187 pubmed: 14662550
Trubetskoy V, Pardiñas AF, Qi T, Panagiotaropoulou G, Awasthi S, Bigdeli TB, et al. Mapping genomic loci implicates genes and synaptic biology in schizophrenia. Nature. 2022;604:502–8.
doi: 10.1038/s41586-022-04434-5 pubmed: 35396580 pmcid: 9392466
Choi SW, Mak TS, O’Reilly PF. Tutorial: a guide to performing polygenic risk score analyses. Nat Protoc. 2020;15:2759–72.
doi: 10.1038/s41596-020-0353-1 pubmed: 32709988 pmcid: 7612115
Stauffer EM, Bethlehem RAI, Warrier V, Murray GK, Romero-Garcia R, Seidlitz J, et al. Grey and white matter microstructure is associated with polygenic risk for schizophrenia. Mol Psychiatry. 2021;26:7709–18.
doi: 10.1038/s41380-021-01260-5 pubmed: 34462574 pmcid: 8872982
Grama S, Willcocks I, Hubert JJ, Pardiñas AF, Legge SE, Bracher-Smith M, et al. Polygenic risk for schizophrenia and subcortical brain anatomy in the UK Biobank cohort. Transl Psychiatry. 2020;10:309.
doi: 10.1038/s41398-020-00940-0 pubmed: 32908133 pmcid: 7481214
Coulthard LG, Hawksworth OA, Woodruff TM. Complement: The Emerging Architect of the Developing Brain. Trends Neurosci. 2018;41:373–84.
doi: 10.1016/j.tins.2018.03.009 pubmed: 29606485
Schafer DP, Lehrman EK, Kautzman AG, Koyama R, Mardinly AR, Yamasaki R, et al. Microglia sculpt postnatal neural circuits in an activity and complement-dependent manner. Neuron. 2012;74:691–705.
doi: 10.1016/j.neuron.2012.03.026 pubmed: 22632727 pmcid: 3528177
Sekar A, Bialas AR, de Rivera H, Davis A, Hammond TR, Kamitaki N, et al. Schizophrenia risk from complex variation of complement component 4. Nature. 2016;530:177–83.
doi: 10.1038/nature16549 pubmed: 26814963 pmcid: 4752392
Woo JJ, Pouget JG, Zai CC, Kennedy JL. The complement system in schizophrenia: where are we now and what’s next? Mol Psychiatry. 2020;25:114–30.
doi: 10.1038/s41380-019-0479-0 pubmed: 31439935
Sellgren CM, Gracias J, Watmuff B, Biag JD, Thanos JM, Whittredge PB, et al. Increased synapse elimination by microglia in schizophrenia patient-derived models of synaptic pruning. Nat Neurosci. 2019;22:374–85.
doi: 10.1038/s41593-018-0334-7 pubmed: 30718903 pmcid: 6410571
Schmitt A, Hasan A, Gruber O, Falkai P. Schizophrenia as a disorder of disconnectivity. Eur Arch Psychiatry Clin Neurosci. 2011;261:S150–154.
doi: 10.1007/s00406-011-0242-2 pubmed: 21866371
Friston KJ, Frith CD. Schizophrenia: a disconnection syndrome? Clin Neurosci. 1995;3:89–97.
pubmed: 7583624
Kelly S, Jahanshad N, Zalesky A, Kochunov P, Agartz I, Alloza C, et al. Widespread white matter microstructural differences in schizophrenia across 4322 individuals: results from the ENIGMA Schizophrenia DTI Working Group. Mol Psychiatry. 2018;23:1261–9.
doi: 10.1038/mp.2017.170 pubmed: 29038599
Zhang H, Schneider T, Wheeler-Kingshott CA, Alexander DC. NODDI: practical in vivo neurite orientation dispersion and density imaging of the human brain. Neuroimage. 2012;61:1000–16.
doi: 10.1016/j.neuroimage.2012.03.072 pubmed: 22484410
Bycroft C, Freeman C, Petkova D, Band G, Elliott LT, Sharp K, et al. The UK Biobank resource with deep phenotyping and genomic data. Nature. 2018;562:203–9.
doi: 10.1038/s41586-018-0579-z pubmed: 30305743 pmcid: 6786975
Frankish A, Diekhans M, Ferreira AM, Johnson R, Jungreis I, Loveland J, et al. GENCODE reference annotation for the human and mouse genomes. Nucleic Acids Res. 2019;47:D766–73.
doi: 10.1093/nar/gky955 pubmed: 30357393
Carpanini SM, Harwood JC, Baker E, Torvell M, The Gerad C, Sims R, et al. The Impact of Complement Genes on the Risk of Late-Onset Alzheimer’s Disease. Genes (Basel) 2021;12:443.
Werme J, van der Sluis S, Posthuma D, de Leeuw CA. An integrated framework for local genetic correlation analysis. Nat Genet. 2022;54:274–82.
doi: 10.1038/s41588-022-01017-y pubmed: 35288712
Franke B, Stein JL, Ripke S, Anttila V, Hibar DP, van Hulzen KJE, et al. Genetic influences on schizophrenia and subcortical brain volumes: large-scale proof of concept. Nat Neurosci. 2016;19:420–31.
doi: 10.1038/nn.4228 pubmed: 26854805 pmcid: 4852730
Reus LM, Shen X, Gibson J, Wigmore E, Ligthart L, Adams MJ, et al. Association of polygenic risk for major psychiatric illness with subcortical volumes and white matter integrity in UK Biobank. Sci Rep. 2017;7:42140.
doi: 10.1038/srep42140 pubmed: 28186152 pmcid: 5301496
Alnæs D, Kaufmann T, van der Meer D, Córdova-Palomera A, Rokicki J, Moberget T, et al. Brain Heterogeneity in Schizophrenia and Its Association With Polygenic Risk. JAMA Psychiatry. 2019;76:739–48.
doi: 10.1001/jamapsychiatry.2019.0257 pubmed: 30969333 pmcid: 6583664
Caseras X, Tansey KE, Foley S, Linden D. Association between genetic risk scoring for schizophrenia and bipolar disorder with regional subcortical volumes. Transl Psychiatry. 2015;5:e692.
doi: 10.1038/tp.2015.195 pubmed: 26645627 pmcid: 5068590
Váša F, Bullmore ET, Patel AX. Probabilistic thresholding of functional connectomes: Application to schizophrenia. Neuroimage. 2018;172:326–40.
doi: 10.1016/j.neuroimage.2017.12.043 pubmed: 29277403
O'Connell KS, Sønderby IE, Frei O, van der Meer D, Athanasiu L, Smeland OB, et al. Association between complement component 4A expression, cognitive performance and brain imaging measures in UK Biobank. Psychol Med. 2021;52:1–11.
pubmed: 33653435
Bralten J, Franke B, Arias-Vásquez A, Heister A, Brunner HG, Fernández G, et al. CR1 genotype is associated with entorhinal cortex volume in young healthy adults. Neurobiol Aging. 2011;32:2106.e2107–11.
doi: 10.1016/j.neurobiolaging.2011.05.017
Allswede DM, Zheutlin AB, Chung Y, Anderson K, Hultman CM, Ingvar M, et al. Complement Gene Expression Correlates with Superior Frontal Cortical Thickness in Humans. Neuropsychopharmacology. 2018;43:525–33.
doi: 10.1038/npp.2017.164 pubmed: 28758643
Sun BB, Maranville JC, Peters JE, Stacey D, Staley JR, Blackshaw J, et al. Genomic atlas of the human plasma proteome. Nature. 2018;558:73–79.
doi: 10.1038/s41586-018-0175-2 pubmed: 29875488 pmcid: 6697541
Thareja G, Belkadi A, Arnold M, Albagha OME, Graumann J, Schmidt F, et al. Differences and commonalities in the genetic architecture of protein quantitative trait loci in European and Arab populations. Hum Mol Genet. 2022;32:907–16.
doi: 10.1093/hmg/ddac243 pmcid: 9990988
Holland JF, Cosgrove D, Whitton L, Harold D, Corvin A, Gill M, et al. Effects of complement gene-set polygenic risk score on brain volume and cortical measures in patients with psychotic disorders and healthy controls. Am J Med Genet B Neuropsychiatr Genet. 2020;183:445–53.
doi: 10.1002/ajmg.b.32820 pubmed: 32918526
Norman PJ, Norberg SJ, Guethlein LA, Nemat-Gorgani N, Royce T, Wroblewski EE, et al. Sequences of 95 human MHC haplotypes reveal extreme coding variation in genes other than highly polymorphic HLA class I and II. Genome Res. 2017;27:813–23.
doi: 10.1101/gr.213538.116 pubmed: 28360230 pmcid: 5411776
Jung W, Lee J, Shin HG, Nam Y, Zhang H, Oh SH, et al. Whole brain g-ratio mapping using myelin water imaging (MWI) and neurite orientation dispersion and density imaging (NODDI). Neuroimage. 2018;182:379–88.
doi: 10.1016/j.neuroimage.2017.09.053 pubmed: 28962901
Fry A, Littlejohns TJ, Sudlow C, Doherty N, Adamska L, Sprosen T, et al. Comparison of Sociodemographic and Health-Related Characteristics of UK Biobank Participants With Those of the General Population. Am J Epidemiol. 2017;186:1026–34.
doi: 10.1093/aje/kwx246 pubmed: 28641372 pmcid: 5860371
Morey RA, Inan S, Mitchell TV, Perkins DO, Lieberman JA, Belger A. Imaging frontostriatal function in ultra-high-risk, early, and chronic schizophrenia during executive processing. Arch Gen Psychiatry. 2005;62:254–62.
doi: 10.1001/archpsyc.62.3.254 pubmed: 15753238 pmcid: 2732718
Bulbul O, Kurt E, Ulasoglu-Yildiz C, Demiralp T, Ucok A. Altered Resting State Functional Connectivity and Its Correlation with Cognitive Functions at Ultra High Risk for Psychosis. Psychiatry Res Neuroimaging. 2022;321:111444.
doi: 10.1016/j.pscychresns.2022.111444 pubmed: 35093807

Auteurs

Xavier Caseras (X)

Centre for Neuropsychiatric Genetics and Genomics, Department of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, UK. CaserasX@cardiff.ac.uk.

Emily Simmonds (E)

Centre for Neuropsychiatric Genetics and Genomics, Department of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, UK.
Dementia Research Institute, London, UK.

Antonio F Pardiñas (AF)

Centre for Neuropsychiatric Genetics and Genomics, Department of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, UK.

Richard Anney (R)

Centre for Neuropsychiatric Genetics and Genomics, Department of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, UK.

Sophie E Legge (SE)

Centre for Neuropsychiatric Genetics and Genomics, Department of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, UK.

James T R Walters (JTR)

Centre for Neuropsychiatric Genetics and Genomics, Department of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, UK.

Neil A Harrison (NA)

Centre for Neuropsychiatric Genetics and Genomics, Department of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, UK.
Cardiff University Brain Research Imaging Centre, Cardiff University, Cardiff, UK.

Michael C O'Donovan (MC)

Centre for Neuropsychiatric Genetics and Genomics, Department of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, UK.

Valentina Escott-Price (V)

Centre for Neuropsychiatric Genetics and Genomics, Department of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, UK.
Dementia Research Institute, London, UK.

Classifications MeSH